A

Anebulo Pharmaceuticals
D

ANEB

1.43000
USD
-0.17
(-10.63%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-5
حجم السوق
37,084,500
الأخبار

العنوان: Anebulo Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.